Related Experiment Video
Updated: May 30, 2026
08:26
Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death
Published on: October 31, 2017
Targeting the ceramide system in cancer.
Brian Henry1, Christina Möller, Marie-Therese Dimanche-Boitrel
1Dept. of Molecular Biology, University of Duisburg-Essen, Hufelandstrasse 55, 45 122 Essen, Germany.
Cancer Letters
|August 25, 2011
Summary
Ceramide, a lipid molecule, plays a key role in cell signaling and cancer treatment. Targeting ceramide production pathways offers a promising strategy for enhancing anti-tumor therapies.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Sphingolipids, particularly ceramide, are crucial in cellular signaling pathways.
- Ceramide synthesis involves sphingomyelin hydrolysis and de novo pathways.
- Sphingomyelinases and ceramide synthases are implicated in cancer treatment responses.
Purpose of the Study:
- To review current evidence on ceramide pathways as targets for cancer therapy.
- To explore novel strategies for tumor treatment based on ceramide metabolism.
Main Methods:
- Literature review of contemporary research on ceramide metabolism and cancer.
- Analysis of studies investigating sphingomyelinases and ceramide synthases in cancer treatment.
Main Results:
- γ-irradiation and chemotherapy induce cell death through ceramide generation.
- Ceramide-forming pathways are significantly affected by cancer treatments.
- Targeting these pathways shows potential for enhancing anti-tumor efficacy.
Conclusions:
- Ceramide production and metabolism are critical targets for novel cancer therapies.
- Manipulating ceramide pathways can improve the effectiveness of existing anti-tumor treatments.
- Further research into ceramide-centric strategies may lead to improved cancer treatment outcomes.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...